Because of their specialized characteristics, cDCs actively capture, internalize, and process the foreign pathogenic Ags and self-non-tumor or tumor-derived Ags and then present to CD4+ and CD8+ T cells via the MHC-II and MHC-I molecules, respectively [18]. The gene discussed is CD4; the disease is neoplasm.